Issue: #1August 2011



- Scientific Advisory Board
- ChemOutsourcing, Long Branch, NJ
- 20/20 Pharma Podcast & New Adesis Whitepaper
- New Compounds for August -  Always In Stock!


In This Issue
Adesis Whitepaper
Scientific Advisory Board
20/20 Pharma Podcast
Compounds of the Month
August Promotion


catalog e-news



join mailing list

Join Our List

Join Our Mailing List

Adesis Whitepaper


Adesis has a Whitepaper, "Orthogonally-functionalized Pyridines from a Drug Discovery and Optimization Perspective", featured on 20/20 Pharma's website. To read or download the paper


Quick Links








Adesis Establishes 

Scientific Advisory Board


Amos Smith                 Martin  


Adesis is pleased to announce the establishment of its Scientific Advisory Board, SAB, and to announce its first two charter members, Professors Amos B. Smith III of the Department of Chemistry at the University of Pennsylvania and Martin F. Semmelhack of the Department of Chemistry at Princeton University



ChemOutsourcing Sept 12-15th

Drop by booth #73 to meet our CEO, Dr. Ving Lee and our VP of Chemistry, Dr. Andrew Cottone

20/20 Pharma Podcast 

Ving J. Lee and Ronald Yarger participated in 20/20 Pharma's Podcast "Working Hand-in-Hand for the Future of Pharma Outsourcing". Visit 20/20 Pharma's website to listen to the podcast    Click here 



20/20 Pharma



Compounds of the Month

Hot New Heterocycles 


Here are just a few of the new compounds introduced this month at Adesis.   Many are novel and the majority are exclusively available through Adesis.  All compounds we list on our website are in stock.  To see all of our new heterocycles  Click here




About Adesis

Adesis, Inc. is a contract research organization (CRO) supporting the pharmaceutical and biopharmaceutical industry, biomaterials and catalysts industry. 


The life science industry has embraced the philosophy of outsourcing reference standards (competitor's drugs), targets, scaffolds, building blocks and advanced intermediates. Outsourcing allows medicinal chemists to focus on design and assembly of new targets for pharmacological evaluation and streamlines the early stage drug discovery process. Similarly, other chemistry-based research organizations (catalysts, biomaterials and fragrances) have accepted similar modus of operendi in order to maximize cost controls, while having timely project successes.


The core foundation of Adesis, Inc. is attributed to our experienced chemists with the expertise to conduct complex multi-step synthetic sequences (typical range of 2 - 20 steps).



We hope you have enjoyed reading our Adesis newsletter.  We welcome your comments.


With Best Wishes,


Paul Beard


If you are interested in how your company can do business with Adesis or to learn more about our capabilities, please contact one of the members of our business development team.


Ronald G. Yarger, PhD

Director, Business Development 

Ph. 302-261-3383; Mobile 302-358-8837 



Paul Beard, MBA BS 

Business Development Associate 

Ph. 302-323-6314; Mobile 302-383-5918                      





August Promotion: Buy 3 get one free

Buy 1 gram each of three catalog compounds get a 4th compound of your choice free.  All three 1 gram orders must be purchased in the same transaction.  Applies to compounds of equal or lesser value.  


Please call Jack Church to place your order: 302-323-6305 or email

Offer Expires: August 31st, 2011 
Only one offer per person.